Literature DB >> 35754599

Successfully treated acute adult T-cell leukemia with haploidentical stem cell transplantation.

Aswani Thurlapati1, Christopher Graham2, Kyle Boudreaux3, Tamna Wangjam2.   

Abstract

Adult T-cell leukemia-lymphoma caused by human T-lymphotropic virus type 1 is a rare and aggressive tumor with high morbidity and mortality. Historically it has been treated with chemotherapy, but more recent studies suggest improvement in survival with the combination of chemotherapy and stem cell transplantation. Our case study reports a middle-aged African American woman with no other risk factors diagnosed with the acute form of adult T-cell leukemia-lymphoma and in remission after completing chemotherapy and a haploidentical stem cell transplantation.
Copyright © 2022 Baylor University Medical Center.

Entities:  

Keywords:  Acute T-cell leukemia; HTLV-1; Shimoyama classification; allogeneic stem cell transplantation

Year:  2022        PMID： 35754599      PMCID： PMC9196777          DOI： 10.1080/08998280.2022.2058901

Source DB:  PubMed          Journal:  Proc (Bayl Univ Med Cent)        ISSN： 0899-8280


  13 in total

1.  HTLV-1 and HTLV-2 prevalence in the United States.

Authors:  Lucy B M Cook; Graham P Taylor
Journal:  J Infect Dis       Date:  2013-10-23       Impact factor: 5.226

Review 2.  The impact of HTLV-1 on the cellular genome.

Authors:  Lucy Cook; Anat Melamed; Hiroko Yaguchi; Charles Rm Bangham
Journal:  Curr Opin Virol       Date:  2017-08-18       Impact factor: 7.090

3.  Complete Remissions of Adult T-cell Leukemia with Anti-CD25 Recombinant Immunotoxin LMB-2 and Chemotherapy to Block Immunogenicity.

Authors:  Robert J Kreitman; Maryalice Stetler-Stevenson; Elaine S Jaffe; Kevin C Conlon; Seth M Steinberg; Wyndham Wilson; Thomas A Waldmann; Ira Pastan
Journal:  Clin Cancer Res       Date:  2015-09-08       Impact factor: 12.531

4.  Mogamulizumab for adult T-cell leukemia-lymphoma: a multicenter prospective observational study.

Authors:  Kentaro Yonekura; Shigeru Kusumoto; Ilseung Choi; Nobuaki Nakano; Asahi Ito; Youko Suehiro; Yoshitaka Imaizumi; Makoto Yoshimitsu; Kisato Nosaka; Eiichi Ohtsuka; Michihiro Hidaka; Tatsuro Jo; Hidenori Sasaki; Yukiyoshi Moriuchi; Masao Ogata; Hiro Tatetsu; Kenji Ishitsuka; Yasushi Miyazaki; Ryuzo Ueda; Atae Utsunomiya; Takashi Ishida
Journal:  Blood Adv       Date:  2020-10-27

5.  Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984-87).

Authors:  M Shimoyama
Journal:  Br J Haematol       Date:  1991-11       Impact factor: 6.998

6.  Treatment and survival among 1594 patients with ATL.

Authors:  Hiroo Katsuya; Kenji Ishitsuka; Atae Utsunomiya; Shuichi Hanada; Tetsuya Eto; Yukiyoshi Moriuchi; Yoshio Saburi; Masaharu Miyahara; Eisaburo Sueoka; Naokuni Uike; Shinichiro Yoshida; Kiyoshi Yamashita; Kunihiro Tsukasaki; Hitoshi Suzushima; Yuju Ohno; Hitoshi Matsuoka; Tatsuro Jo; Masahiro Amano; Ryosuke Hino; Mototsugu Shimokawa; Kazuhiro Kawai; Junji Suzumiya; Kazuo Tamura
Journal:  Blood       Date:  2015-09-11       Impact factor: 22.113

7.  Seroprevalence and demographic determinants of human T-lymphotropic virus type 1 and 2 infections among first-time blood donors--United States, 2000-2009.

Authors:  Yun Brenda Chang; Zhanna Kaidarova; Daniel Hindes; Marjorie Bravo; Nancy Kiely; Hany Kamel; Denise Dubay; Barbara Hoose; Edward L Murphy
Journal:  J Infect Dis       Date:  2013-09-24       Impact factor: 5.226

Review 8.  A Review of New Findings in Adult T-cell Leukemia-Lymphoma: A Focus on Current and Emerging Treatment Strategies.

Authors:  Olivier Hermine; Juan Carlos Ramos; Kensei Tobinai
Journal:  Adv Ther       Date:  2018-02-06       Impact factor: 3.845

Review 9.  Maintenance of long remission in adult T-cell leukemia by Tax-targeted vaccine: A hope for disease-preventive therapy.

Authors:  Mari Kannagi; Atsuhiko Hasegawa; Yoshiko Nagano; Tadafumi Iino; Jun Okamura; Youko Suehiro
Journal:  Cancer Sci       Date:  2019-02-19       Impact factor: 6.716

Review 10.  Novel Treatments of Adult T Cell Leukemia Lymphoma.

Authors:  Hiba El Hajj; Kunihiro Tsukasaki; Morgane Cheminant; Ali Bazarbachi; Toshiki Watanabe; Olivier Hermine
Journal:  Front Microbiol       Date:  2020-05-28       Impact factor: 5.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.